About
in vivo CAR T Gene Therapy
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapyBoston & New England
Team (13)
Aditi Soni
VP, Program & Alliance Management
Kelonia Therapeutics
executive
Bob More
Managing Director, Alta Partners
Kelonia Therapeutics
team_member
Bryan Roberts
Partner, Venrock
Kelonia Therapeutics
team_member
Kevin Friedman
Founder & Chief Executive Officer
Kelonia Therapeutics
executivefounder
Kristen Hege
Retired SVP, Early Clinical Development, Hematology/Oncology & Cell Therapy Bristol Myers Squibb
Kelonia Therapeutics
team_member
Mathai Mammen
CEO, Parabilis Medicines
Kelonia Therapeutics
executive
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
1
As Collaborator
0
Total Enrollment
40
By Phase
PHASE1: 1
By Status
RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
Hover over trial bars to see details
Funding History (1)
D
Apr 29, 2022
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...